Abstract:Although sleep is a ubiquitous behavior in animal species with well-developed central nervous systems, many aspects in the neurobiology of sleep remain mysterious. Our discovery of orexin, a hypothalamic neuropeptide involved in the maintenance of wakefulness, has triggered an intensive research examining the exact role of the orexinergic and other neural pathways in the regulation of sleep/wakefulness. The orexin receptor antagonist suvorexant, which specifically block the endogenous waking system, has been approved as a new drug to treat insomnia. Also, since the sleep disorder narcolepsy-cataplexy is caused by orexin deficiency, orexin receptor agonists are expected to provide mechanistic therapy for narcolepsy; they will likely be also useful for treating excessive sleepiness due to other etiologies.Despite the fact that the executive neurocircuitry and neurochemistry for sleep/wake switching has been increasingly revealed in recent years, the mechanism for homeostatic regulation of sleep, as well as the neural substrate for "sleepiness" (sleep need), remains unknown. To crack open this black box, we have initiated a large-scale forward genetic screen of sleep/wake phenotype in mice based on true somnographic (EEG/EMG) measurements. We have so far screened >8,000 heterozygous ENU-mutagenized founders and established a number of pedigrees exhibiting heritable and specific sleep/wake abnormalities. By combining linkage analysis and the next-generation whole exome sequencing, we have molecularly identified and verified the causal mutation in several of these pedigrees. Biochemical and neurophysiological analyses of these mutations are underway. Since these dominant mutations cause strong phenotypic traits, we expect that the mutated genes will provide new insights into the elusive pathway regulating sleep/wakefulness. Indeed, through a systematic cross-comparison of the Sleepy mutants and sleep-deprived mice, we have recently found that the cumulative phosphorylation state of a specific set of mostly synaptic proteins may be the molecular substrate of sleep need.

Reversal of Obesity by Enhancing Slow-wave Sleep via a Prokineticin Receptor Neural Circuit

Reciprocal control of obesity and anxiety–depressive disorder via a GABA and serotonin neural circuit

Reversal of obesogenic feeding and hypometabolism by a bifurcating GABAergic neural circuit

Short Neuropeptide F is a Sleep-Promoting Inhibitory Modulator.

Sleep Extension: A Potential Target for Obesity Treatment

5-HT Neurons Integrate GABA and Dopamine Inputs to Regulate Meal Initiation

Metabolomics Analysis on Obesity-Related Obstructive Sleep Apnea After Weight Loss Management: A Preliminary Study

Identification of a GABAergic Neural Circuit Governing Leptin Signaling Deficiency-Induced Obesity

Toward the Mysteries of Sleep

AKH-FOXO Pathway Regulates Starvation-Induced Sleep Loss Through Remodeling of the Small Ventral Lateral Neuron Dorsal Projections

Chronic sleep fragmentation during the sleep period induces hypothalamic endoplasmic reticulum stress and PTP1b-mediated leptin resistance in male mice

Rediscovering a Forgotten Link: TSPO and RIM-BP1 in Appetite Regulation

The Importance of Sleep in Overcoming Childhood Obesity and Reshaping Epigenetics

Intraventricular Injection of LKB1 Inhibits the Formation of Diet-Induced Obesity in Rats by Activating the AMPK-POMC Neurons-Sympathetic Nervous System Axis

Pro-opiomelanocortin Gene Transfer to the Nucleus of the Solitary Track but Not Arcuate Nucleus Ameliorates Chronic Diet-Induced Obesity

The Lateral Hypothalamic and BNST GABAergic Projections to the Anterior Ventrolateral Periaqueductal Gray Regulate Feeding

A Selective Bombesin Receptor Subtype 3 Agonist Promotes Weight Loss in Diet-Induced–Obese Rats With Circadian Rhythm Change

239-LB: Single-Cell Analysis Identified Inhibitory Neurons Associated with High-Fat Diet in the Bed Nucleus of the Stria Terminalis

Circadian Intervention of Obesity Development Via Resting-Stage Feeding Manipulation or Oxytocin Treatment.

Sleep deprivation induced fat accumulation in the visceral white adipose tissue by suppressing SIRT1/FOXO1/ATGL pathway activation

Antiobesity molecular mechanisms of action: Resveratrol and pterostilbene